OSA
Conditions
Brief summary
The REMAP study aims to follow a cohort of 400 patients in around ten sleep centers in France and to collect clinical routine data. The objectives of this study are to investigate the effects of one-year management of OSA by CPAP or MAD on sleep architecture defined by objective macro and micro sleep architecture parameters using a sleep test device. sleep connected at home, to assess the quality of sleep and the quality of life reported by patients. The study will also allow us to define predictive factors for improving sleep quality during OSA treatment.
Interventions
DEVICECPAP
Fixed-pressure CPAP device for the treatment of sleep apnea with optional humidification and heated circuit. This device is a Class II device. It has a remote monitoring function allowing service providers to track the use of the device.
DEVICEMAD
mandibular device orthosis made to measure from the dental impressions of patients, made by the specialist in the masticatory apparatus for the treatment of sleep apnea.
Sponsors
ResMed
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
* Patient already included in the SunSAS study (No. ID/RCB: 2021-A01827-34) or Patient who has undergone polygraphy or polysomnography eligible for treatment with CPAP or MAD in the context of OSA. * Patient with a sleep test performed with the Sunrise device * Men or Women from 18 to 80 years old * Patient with OSAS eligible for CPAP or MAD therapy * Affiliated patient or beneficiary of a social security scheme * Signed informed consent
Exclusion criteria
* Patient previously treated for OSAS by CPAP or MAD during the last five years * Patient with COPD or other respiratory diseases. * Patient with contraindications to PPC or MAD therapy * Patient with unstable heart disease or New York Heart Association class III or IV heart failure * Patient unable to complete the study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To determine the evolution of deep slow-wave sleep at one year in OSA patients according to the treatment initiated by continuous positive pressure or mandibular advancement device (MAD). | 12 months | Objective evolution of deep slow-wave sleep time. Changes collected with a home-connected sleep testing device by comparing data from the initial visit (diagnosis) with data collected at 12 months (± 2 weeks) in a patient treated with CPAP or MAD. |
Countries
France
Contacts
Primary ContactElodie Aversenq
Backup ContactFlorent Lavergne
Outcome results
None listed